We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-2.79%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$79.9M
AUM Growth
-$13.3M
(-14%)
Cap. Flow
-$6.02M
Cap. Flow
% of AUM
-7.53%
Top 10 Holdings %
Top 10 Hldgs %
34.04%
Holding
129
New
8
Increased
21
Reduced
42
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IZEA Worldwide
IZEA
|
+$1.1M |
| 2 |
TEAR
TearLab Corporation
TEAR
|
+$1.09M |
| 3 |
Fastenal
FAST
|
+$1.08M |
| 4 |
CAB
Cabela's Inc
CAB
|
+$887K |
| 5 |
Medtronic
MDT
|
+$870K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deluxe
DLX
|
+$1.69M |
| 2 |
UnitedHealth
UNH
|
+$1.57M |
| 3 |
MEET
The Meet Group, Inc. Common Stock
MEET
|
+$1.38M |
| 4 |
Global Payments
GPN
|
+$1.26M |
| 5 |
ASRT
Assertio
ASRT
|
+$1.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.52% |
| 2 | Technology | 12.77% |
| 3 | Industrials | 9.85% |
| 4 | Consumer Staples | 7.08% |
| 5 | Communication Services | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $4.73M | 5.92% |
85,938
-4,250
| -5% | -$232K |
|
2
NeoGenomics
NEO
$2.32B
| $4.7M | 5.88% |
697,482
-6,950
| -1% | -$45.7K |
|
3
Rockwell Medical
RMTI
$32.9M
| $3.59M | 4.5% |
4,350
-78
| -2% | -$61.3K |
|
4
Axogen
AXGN
$2.77B
| $3.39M | 4.25% |
633,133
-10,625
| -2% | -$53.9K |
|
5
LeMaitre Vascular
LMAT
$1.84B
| $2.26M | 2.83% |
145,898
-304
| -0.2% | -$4.36K |
|
6
ePlus
PLUS
$2.28B
| $1.86M | 2.33% |
92,400
+400
| +0.4% | +$8.25K |
|
7
Pfizer
PFE
$159B
| $1.83M | 2.29% |
65,010
| – | – |
|
8
Altimmune
ALT
$605M
| $1.8M | 2.26% |
3,179
-803
| -20% | -$411K |
|
|
SVU
9
DELISTED
SUPERVALU Inc.
SVU
| $1.52M | 1.91% |
37,736
+857
| +2% | +$30.5K |
|
10
Vericel Corp
VCEL
$2.1B
| $1.5M | 1.88% |
256,500
-2,750
| -1% | -$7.71K |
|
11
Eli Lilly
LLY
$1.05T
| $1.42M | 1.78% |
19,700
-600
| -3% | -$45.4K |
|
12
AtriCure
ATRC
$2.47B
| $1.42M | 1.77% |
84,200
-50
| -0.1% | -$880 |
|
|
BEAT
13
DELISTED
BioTelemetry, Inc.
BEAT
| $1.41M | 1.76% |
120,250
+1,200
| +1% | +$13.4K |
|
14
CVS Health
CVS
$119B
| $1.26M | 1.58% |
12,183
| – | – |
|
|
HDS
15
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.25M | 1.57% |
37,850
-1,350
| -3% | -$37.2K |
|
|
16
Fastenal
FAST
$57.1B
| $1.22M | 1.53% |
+99,600
| New | +$1.08M |
|
|
ZIXI
17
DELISTED
Zix Corporation
ZIXI
| $1.22M | 1.52% |
309,039
-2,800
| -0.9% | -$11.7K |
|
18
Xtant Medical Holdings
XTNT
$53.9M
| $1.17M | 1.46% |
35,981
+748
| +2% | +$23.9K |
|
19
AT&T
T
$178B
| $1.16M | 1.45% |
39,140
+9,665
| +33% | +$268K |
|
20
Altria Group
MO
$115B
| $1.15M | 1.44% |
18,400
+8,650
| +89% | +$523K |
|
|
CGNT
21
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.15M | 1.43% |
1,041,261
-98,593
| -9% | -$111K |
|
|
NSPH
22
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $1.12M | 1.4% |
1,413,494
-127,100
| -8% | -$91.9K |
|
23
Idexx Laboratories
IDXX
$43.7B
| $1.1M | 1.37% |
14,000
| – | – |
|
24
AbbVie
ABBV
$451B
| $1.05M | 1.32% |
18,475
| – | – |
|
25
Microsoft
MSFT
$3.81T
| $1.03M | 1.3% |
18,735
+3,600
| +24% | +$189K |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Perkins Capital Management held 129 positions worth $79.9M, down 14% from $93.2M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Perkins Capital Management withdrew a net $6.02M in Q1 2016, closing 12 positions and reducing 42 holdings. Its most notable exit was Deluxe, an estimated $1.69M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in IZEA Worldwide worth $1.02M.
- Perkins Capital Management's largest Q1 2016 buy was IZEA Worldwide: 35,796 shares worth $1.02M.
- Perkins Capital Management added most to TearLab Corporation in Q1 2016, an estimated $1.09M increase.
- Perkins Capital Management's biggest Q1 2016 reduction was Assertio, cutting an estimated $1.07M.
- Perkins Capital Management fully exited Deluxe in Q1 2016, selling an estimated $1.69M.
- Perkins Capital Management's ten largest holdings make up 34% of its $79.9M portfolio in Q1 2016.
- Perkins Capital Management opened 8 new positions and closed 12 in Q1 2016.
- Perkins Capital Management's portfolio value fell 14% quarter-over-quarter to $79.9M.
Based on Perkins Capital Management's 13F filing for Q1 2016, filed 18 Apr 2016.